Establishment Labs Announces Motiva® Implants IDE Clinical Trial Underway with First Patient Enrolled and Surgery Completed
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the enrollment and successful completion of implant surgery on the first patient in its U.S. investigational device exemption (IDE) clinical trial of its Motiva®
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2018-04-27 17:28:562018-04-27 17:28:56Establishment Labs Announces Motiva® Implants IDE Clinical Trial Underway with First Patient Enrolled and Surgery Completed
Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, announced today that it has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a clinical […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2018-03-22 17:49:272018-03-22 17:51:39Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants
Establishment Labs Appoints Dennis Condon to the Board of Directors
NEW YORK, Jan. 8, 2018 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, announced today that Dennis Condon has been appointed to the Board of Directors. Mr. Condon brings years of experience in the breast implant market from […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2018-01-08 19:39:532018-01-08 19:40:08Establishment Labs Appoints Dennis Condon to the Board of Directors
Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the launch of the MotivaImagine Ultralight LED in partnership with OBP Medical, creators of the award winning ONETRAC Retractor family. Surgical kits designed to support placement […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-11-29 20:16:332017-11-29 20:16:33Establishment Labs and OBP Medical Announce Partnership to Deliver Innovative New Tool for Advanced Breast Aesthetics Procedures
Establishment Labs Announces Positive Clinical Study Results for its Motiva Implants® Published in the Aesthetics Surgery Journal
NEW YORK, September 14, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that the results of a three-year, retrospective clinical study using the Company’s Motiva Implants® were published in the peer-reviewed Aesthetic Surgery Journal. The study evaluated the […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-09-20 16:59:552017-09-20 17:13:19Establishment Labs Announces Positive Clinical Study Results for its Motiva Implants® Published in the Aesthetics Surgery Journal
Establishment Labs Announces $55 Million Combined Debt and Equity Financing
NEW YORK, August 28, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that it has closed a $55 million combined secured credit facility and equity investment with Madryn Asset Management. “This transaction allows us to finance our research […]
Establishment Labs Announces Leadership for Energy and Environmental Design (LEED) Gold Certification on its Headquarters in Costa Rica
NEW YORK, August 10, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation announced today that it has received U.S. Green Building Council’s (USGBC) Leadership for Energy and Environmental Design (LEED) Gold Certification on its new headquarters in Costa Rica. “This […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-08-10 13:49:022017-08-10 13:49:02Establishment Labs Announces Leadership for Energy and Environmental Design (LEED) Gold Certification on its Headquarters in Costa Rica
Establishment Labs Submits Investigational Device Exemption (IDE) Filing for Prospective Clinical Trial of Motiva Implants
NEW YORK, August 7, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that it has submitted an Investigational Device Exemption (IDE) filing to the U.S. Food and Drug Administration (FDA) for its Motiva Implants®, the lead product in […]
Establishment Labs Obtains Medical Device Single Audit Program (MDSAP) Regulatory Certification
Certification Assures Compliance with FDA Quality Management System (QMS) Regulation NEW YORK, July 25, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation announced today that it has received the Medical Device Single Audit Program (MDSAP) regulatory certification of its two […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-07-26 00:45:592017-07-26 00:45:59Establishment Labs Obtains Medical Device Single Audit Program (MDSAP) Regulatory Certification
Establishment Labs Announces the Appointment of Renee Gaeta as Chief Financial Officer
NEW YORK, July 12, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation announced today that Renee Gaeta has been appointed Chief Financial Officer, effective immediately. “We are delighted to welcome Renee to our team. Her impressive background in finance and […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-07-12 21:18:182017-07-12 21:18:18Establishment Labs Announces the Appointment of Renee Gaeta as Chief Financial Officer
Establishment Labs Announces Initial Data Regarding Its SilkSurface® Technology as Presented by Professor Robert Langer at the Recent Beauty Through Science (BTS) Congress
NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical technology company focused on aesthetic technologies with a strong emphasis on product development and innovation, today announced that Professor Robert Langer, Chairman of its Scientific Advisory Board, presented initial data highlighting the benefits of the company’s proprietary SilkSurface® technology at the recent, 13th […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-07-10 20:38:462017-07-10 20:38:53Establishment Labs Announces Initial Data Regarding Its SilkSurface® Technology as Presented by Professor Robert Langer at the Recent Beauty Through Science (BTS) Congress
Establishment Labs Announces the Addition of Professor Alexandre Mendonça Munhoz, M.D., Ph.D., to its Medical Advisory Board
Company Announces the Commercial Launch of Motiva Implants® in Brazil NEW YORK, June 29, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced the addition of Alexandre Mendonça Munhoz, M.D., Ph.D., to the company’s Medical Advisory Board. The appointment was […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-06-30 01:57:222017-07-10 20:39:09Establishment Labs Announces the Addition of Professor Alexandre Mendonça Munhoz, M.D., Ph.D., to its Medical Advisory Board
Establishment Labs Announces Certification of its Second Facility in Costa Rica
Second manufacturing facility in Costa Rica has received certification and begun shipping units to Europe and around the world. This new site, in combination with the company’s existing facility, extends manufacturing capacity by 4X and enables the company to expand its distribution capability. NEW YORK, NY (PRWEB) JUNE 02, 2017 Establishment Labs, a global medical […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-06-02 15:26:112017-06-02 15:26:17Establishment Labs Announces Certification of its Second Facility in Costa Rica
Establishment Labs Expands Management Team with Key Addition in Quality Assurance and Regulatory Affairs
NEW YORK, NY (PRWEB) MAY 26, 2017 Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the expansion of its leadership team with the addition of Alberto Quesada as Vice President of Quality Assurance & Regulatory Affairs. “We are pleased to add […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-05-26 13:36:062017-05-26 13:36:06Establishment Labs Expands Management Team with Key Addition in Quality Assurance and Regulatory Affairs
Establishment Labs Announces Close of $18M Financing Round
The funding will be used primarily to support the international launch of Motiva Implants® and Puregraft® in new markets NEW YORK, NY (PRWEB) APRIL 17, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has closed an $18 […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-04-17 21:41:172017-04-17 21:41:17Establishment Labs Announces Close of $18M Financing Round
Establishment Labs Announces Regulatory Clearances in Brazil
Establishment Labs Announces Regulatory Clearances in Brazil NEW YORK, NY (PRWEB) MARCH 31, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has received regulatory approval from the Brazilian National Health Surveillance Agency (ANVISA) to market Motiva Implants® […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2017-03-31 19:00:472017-04-08 23:17:36Establishment Labs Announces Regulatory Clearances in Brazil
Establishment Labs Announces Opening of New Medical Device Manufacturing Facility
Investment of $16.5M in the new manufacturing facility will support its growing international market presence NEW YORK, NY (PRWEB) DECEMBER 15, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today the opening of a state of the art silicone medical […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-12-15 19:01:342017-03-24 19:06:13Establishment Labs Announces Opening of New Medical Device Manufacturing Facility
New Technology by Establishment Labs Results in Increased Safety for Patients Seeking Breast Augmentation
Patient centric innovation is cornerstone of new Safety Campaign NEW YORK, NY (PRWEB) OCTOBER 17, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, today announced the launch of the Motiva Safety Campaign featuring Motiva Implants® with Q Inside Safety Technology™. The […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-10-17 19:09:512017-03-24 19:11:44New Technology by Establishment Labs Results in Increased Safety for Patients Seeking Breast Augmentation
Establishment Labs and Puregraft Announce Strategic Partnership
An exclusive international distribution transaction marries advanced breast implants and autologous fat transfers NEW YORK, NY (PRWEB) SEPTEMBER 14, 2016 Establishment Labs, a global medical device company focused on next-generation breast implants and other innovative medical device technologies, announced today that it has entered into an exclusive agreement to distribute Puregraft’s® line of autologous fat […]
Establishment Labs Announces Completion of a $28 Million Financing
NEW YORK, NY (PRWEB) JULY 20, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced that existing investors exercised their option to invest an additional $6.84 Million, completing a $28 Million financing. Investors in the financing include Crown Predator Holdings (CPH), JW […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-07-20 04:36:582016-07-20 04:40:02Establishment Labs Announces Completion of a $28 Million Financing
Establishment Labs Receives Korean Regulatory Approval for Motiva Implants
Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today that it has received approval from the Korean Food & Drug Administration (KFDA). Establishment Labs also announced a 10 year distribution agreement with Seoul-based Human Wellness Corporation (HWC) to market Motiva Implants® […]
JAMM Technologies Acquires the Veriteq RFID Technology Platform and Enters into Supply Agreement with Establishment Labs
MINNEAPOLIS, MN (PRWEB) APRIL 04, 2016 JAMM Technologies, LLC announced today that it has purchased a portfolio of assets from Veriteq Corporation, including its implantable RFID solutions, UDI business and intellectual property. The company also disclosed that it has entered into a long term supply agreement with Establishment Labs to provide implantable micro-transponder technology for […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-04-04 23:34:202016-06-16 22:04:02JAMM Technologies Acquires the Veriteq RFID Technology Platform and Enters into Supply Agreement with Establishment Labs
Establishment Labs Announces the Appointment of Dr. Brian Kinney to its Scientific Advisory Board
NEW YORK, NY (PRWEB) MARCH 29, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today that Brian Kinney, MD, FACS has joined its Scientific Advisory Board to assist the company in the advancement of its research and development of the […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-03-29 00:08:462016-06-16 22:05:03Establishment Labs Announces the Appointment of Dr. Brian Kinney to its Scientific Advisory Board
Establishment Labs Announces Senior Executive Hires to its Global Sales Team
NEW YORK, NY (PRWEB) MARCH 17, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced two additional hires to its senior executive sales team today. The enhanced international sales team and structure shall become effective on April 1st of this year. […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-03-17 00:09:302016-06-16 22:06:22Establishment Labs Announces Senior Executive Hires to its Global Sales Team
Establishment Labs Announces the Appointment of Dr. David Hung to Its Board of Directors
NEW YORK, NY (PRWEB) FEBRUARY 09, 2016 Establishment Labs, a global breast implant and medical technology company, is pleased to announce the appointment of Dr. David Hung to the company´s Board of Directors. “We are honored to welcome David to our Board of Directors. He is a world class scientist and an exceptional entrepreneur.” said […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-02-09 22:08:162016-06-16 22:09:42Establishment Labs Announces the Appointment of Dr. David Hung to Its Board of Directors
Establishment Labs Announces Appointment of Dr. Scott Spear to its Medical Advisory Board
NEW YORK, NY (PRWEB) JANUARY 25, 2016 Establishment Labs, a global next generation breast implant and medical technology company, announced today that Dr. Scott L.Spear has joined its Medical Advisory Board. “We are partnering with the best minds in plastic surgery to bring the latest technological innovations in breast implants to the United States market. […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-01-25 22:09:492016-06-16 22:11:15Establishment Labs Announces Appointment of Dr. Scott Spear to its Medical Advisory Board
Establishment Labs Announces M.I.T. Professor Dr. Robert Langer is Joining Scientific Advisory Board
NEW YORK, NY (PRWEB) JANUARY 11, 2016 Establishment Labs announced today that M.I.T. Professor Dr. Robert Langer, winner of the prestigious Lemelson-M.I.T. Innovation Prize, will join its Scientific Advisory Board. “Our company is delighted to welcome Dr. Langer to our innovation team,” said Juan Jose Chacon Quiros, CEO of Establishment Labs. “We take women’s health […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-01-11 22:11:212016-06-16 22:15:16Establishment Labs Announces M.I.T. Professor Dr. Robert Langer is Joining Scientific Advisory Board
Establishment Labs Announces the Appointment of Lisa Colleran, Ed Schutter and Allan Weinstein to its Board of Directors
NEW YORK, NY (PRWEB) JANUARY 05, 2016 “Lisa, Ed, and Allan bring a wealth of knowledge and experience to Establishment Labs that will complement our current Board and Management team,” said Juan Jose Chacon Quiros, CEO of Establishment Labs. “Their unique combination of skills and talents will help us achieve our goal of becoming the […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2016-01-05 22:15:342016-06-16 22:19:59Establishment Labs Announces the Appointment of Lisa Colleran, Ed Schutter and Allan Weinstein to its Board of Directors
NEW YORK, NY (PRWEB) SEPTEMBER 28, 2015 Establishment Labs, SA, manufacturer of Motiva Implant Matrix® Silicone Breast Implants (http://www.motivaimplants.com) today announced the appointment of Rudy Mazzocchi as Executive Chairman to lead the Board of Directors and oversee both the company’s Research and Development as well as begin the process to enter the North American markets. […]
Establishment Labs receives Growth Capital Financing in round led by Crown Predator Holdings and JW Asset Management.
NEW YORK, NY- SEPTEMBER 16, 2015 (PRWEB) SEPTEMBER 17, 2015 “Our mission is to make breast aesthetics safer and better for women worldwide by delivering a world class technology platform that promotes women’s health and enables the strategic adoption of Motiva as the brand of choice in the market,” said Juan José Chacón-Quirós, CEO of […]
https://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.png00Mariohttps://establishmentlabs.com/wp-content/uploads/2019/07/el-logo-2018.pngMario2015-09-17 22:26:582016-06-16 22:35:10Establishment Labs receives Growth Capital Financing in round led by Crown Predator Holdings and JW Asset Management.
NEW YORK, April 27, 2018 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies, today announced the enrollment and successful completion of implant surgery on the first patient in its U.S. investigational device exemption (IDE) clinical trial of its Motiva®
NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, announced today that it has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a clinical […]
NEW YORK, Jan. 8, 2018 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development and innovation, announced today that Dennis Condon has been appointed to the Board of Directors. Mr. Condon brings years of experience in the breast implant market from […]
NEW YORK, Nov. 29, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the launch of the MotivaImagine Ultralight LED in partnership with OBP Medical, creators of the award winning ONETRAC Retractor family. Surgical kits designed to support placement […]
NEW YORK, September 14, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that the results of a three-year, retrospective clinical study using the Company’s Motiva Implants® were published in the peer-reviewed Aesthetic Surgery Journal. The study evaluated the […]
NEW YORK, August 28, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that it has closed a $55 million combined secured credit facility and equity investment with Madryn Asset Management. “This transaction allows us to finance our research […]
NEW YORK, August 10, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation announced today that it has received U.S. Green Building Council’s (USGBC) Leadership for Energy and Environmental Design (LEED) Gold Certification on its new headquarters in Costa Rica. “This […]
NEW YORK, August 7, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today that it has submitted an Investigational Device Exemption (IDE) filing to the U.S. Food and Drug Administration (FDA) for its Motiva Implants®, the lead product in […]
Certification Assures Compliance with FDA Quality Management System (QMS) Regulation NEW YORK, July 25, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation announced today that it has received the Medical Device Single Audit Program (MDSAP) regulatory certification of its two […]
NEW YORK, July 12, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation announced today that Renee Gaeta has been appointed Chief Financial Officer, effective immediately. “We are delighted to welcome Renee to our team. Her impressive background in finance and […]
NEW YORK, July 10, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical technology company focused on aesthetic technologies with a strong emphasis on product development and innovation, today announced that Professor Robert Langer, Chairman of its Scientific Advisory Board, presented initial data highlighting the benefits of the company’s proprietary SilkSurface® technology at the recent, 13th […]
Company Announces the Commercial Launch of Motiva Implants® in Brazil NEW YORK, June 29, 2017 (GLOBE NEWSWIRE) Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced the addition of Alexandre Mendonça Munhoz, M.D., Ph.D., to the company’s Medical Advisory Board. The appointment was […]
Second manufacturing facility in Costa Rica has received certification and begun shipping units to Europe and around the world. This new site, in combination with the company’s existing facility, extends manufacturing capacity by 4X and enables the company to expand its distribution capability. NEW YORK, NY (PRWEB) JUNE 02, 2017 Establishment Labs, a global medical […]
NEW YORK, NY (PRWEB) MAY 26, 2017 Establishment Labs, a global medical device company focused on aesthetic technologies with a strong emphasis on product development and innovation, announced today the expansion of its leadership team with the addition of Alberto Quesada as Vice President of Quality Assurance & Regulatory Affairs. “We are pleased to add […]
The funding will be used primarily to support the international launch of Motiva Implants® and Puregraft® in new markets NEW YORK, NY (PRWEB) APRIL 17, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has closed an $18 […]
Establishment Labs Announces Regulatory Clearances in Brazil NEW YORK, NY (PRWEB) MARCH 31, 2017 Establishment Labs, a global medical device company focused on breast surgery technologies with a strong emphasis on product development and innovation, announced today that it has received regulatory approval from the Brazilian National Health Surveillance Agency (ANVISA) to market Motiva Implants® […]
Investment of $16.5M in the new manufacturing facility will support its growing international market presence NEW YORK, NY (PRWEB) DECEMBER 15, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today the opening of a state of the art silicone medical […]
Patient centric innovation is cornerstone of new Safety Campaign NEW YORK, NY (PRWEB) OCTOBER 17, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, today announced the launch of the Motiva Safety Campaign featuring Motiva Implants® with Q Inside Safety Technology™. The […]
An exclusive international distribution transaction marries advanced breast implants and autologous fat transfers NEW YORK, NY (PRWEB) SEPTEMBER 14, 2016 Establishment Labs, a global medical device company focused on next-generation breast implants and other innovative medical device technologies, announced today that it has entered into an exclusive agreement to distribute Puregraft’s® line of autologous fat […]
NEW YORK, NY (PRWEB) JULY 20, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced that existing investors exercised their option to invest an additional $6.84 Million, completing a $28 Million financing. Investors in the financing include Crown Predator Holdings (CPH), JW […]
Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today that it has received approval from the Korean Food & Drug Administration (KFDA). Establishment Labs also announced a 10 year distribution agreement with Seoul-based Human Wellness Corporation (HWC) to market Motiva Implants® […]
MINNEAPOLIS, MN (PRWEB) APRIL 04, 2016 JAMM Technologies, LLC announced today that it has purchased a portfolio of assets from Veriteq Corporation, including its implantable RFID solutions, UDI business and intellectual property. The company also disclosed that it has entered into a long term supply agreement with Establishment Labs to provide implantable micro-transponder technology for […]
NEW YORK, NY (PRWEB) MARCH 29, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced today that Brian Kinney, MD, FACS has joined its Scientific Advisory Board to assist the company in the advancement of its research and development of the […]
NEW YORK, NY (PRWEB) MARCH 17, 2016 Establishment Labs, a global medical device company focused on breast implant technologies with a strong emphasis on product development and innovation, announced two additional hires to its senior executive sales team today. The enhanced international sales team and structure shall become effective on April 1st of this year. […]
NEW YORK, NY (PRWEB) FEBRUARY 09, 2016 Establishment Labs, a global breast implant and medical technology company, is pleased to announce the appointment of Dr. David Hung to the company´s Board of Directors. “We are honored to welcome David to our Board of Directors. He is a world class scientist and an exceptional entrepreneur.” said […]
NEW YORK, NY (PRWEB) JANUARY 25, 2016 Establishment Labs, a global next generation breast implant and medical technology company, announced today that Dr. Scott L.Spear has joined its Medical Advisory Board. “We are partnering with the best minds in plastic surgery to bring the latest technological innovations in breast implants to the United States market. […]
NEW YORK, NY (PRWEB) JANUARY 11, 2016 Establishment Labs announced today that M.I.T. Professor Dr. Robert Langer, winner of the prestigious Lemelson-M.I.T. Innovation Prize, will join its Scientific Advisory Board. “Our company is delighted to welcome Dr. Langer to our innovation team,” said Juan Jose Chacon Quiros, CEO of Establishment Labs. “We take women’s health […]
NEW YORK, NY (PRWEB) JANUARY 05, 2016 “Lisa, Ed, and Allan bring a wealth of knowledge and experience to Establishment Labs that will complement our current Board and Management team,” said Juan Jose Chacon Quiros, CEO of Establishment Labs. “Their unique combination of skills and talents will help us achieve our goal of becoming the […]
NEW YORK, NY (PRWEB) SEPTEMBER 28, 2015 Establishment Labs, SA, manufacturer of Motiva Implant Matrix® Silicone Breast Implants (http://www.motivaimplants.com) today announced the appointment of Rudy Mazzocchi as Executive Chairman to lead the Board of Directors and oversee both the company’s Research and Development as well as begin the process to enter the North American markets. […]
NEW YORK, NY- SEPTEMBER 16, 2015 (PRWEB) SEPTEMBER 17, 2015 “Our mission is to make breast aesthetics safer and better for women worldwide by delivering a world class technology platform that promotes women’s health and enables the strategic adoption of Motiva as the brand of choice in the market,” said Juan José Chacón-Quirós, CEO of […]